Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 27th March 2019 from 11:00 AM to 1:00 PM (GMT).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 10, 2015
Previous Article Next Article

Evaluation of binding competition and group epitopes of acetylcholinesterase inhibitors by STD NMR, Tr-NOESY, DOSY and molecular docking: an old approach but new findings

Author affiliations

Abstract

Acetylcholinesterase is an important enzyme, currently used as therapy for controlling the effects of Alzheimer's disease that has been accepted as one of the major threats to the elderly population. In this perspective, NMR-based binding studies were performed to probe the interligand binding competition and the inhibition potential aiming at a selected target. In the ligand recognition assay, the acetylcholinesterase–inhibitor complex was also validated through a site-specific inhibitor, gallic acid—a known competitive inhibitor. The STD competition experiments demonstrated that both inhibitors did not compete with gallic acid for the particular binding site. However, in competition STD experiments, the order of binding potential has also been calculated, which ranked gallic acid at the highest with 157 μM and 4-methylumbelliferone at the lowest with 165 μM KD value. Moreover, binding conformations and diffusion coefficients were calculated by using Tr-NOESY and DOSY, respectively. Finally, the dissociation constant (KD) information from DOSY was also calculated, which interestingly mimics exactly the pattern of the earlier STD-titration result. Following these NMR outcomes, docking simulations were applied and gallic acid was found as the second potent inhibitor with −5.0195 kcal mol−1 after 4-methylumbelliferone with a −5.4894 kcal mol−1 binding energy. From these realistic NMR results and theoretical docking approach, we envisioned that the utilized molecular scaffolds or their extensions might be used in the control of Alzheimer's disease. Moreover, these scaffolds could also be helpful in generating the rational design of some novel inhibitors with increased potency and even greater specificity.

Graphical abstract: Evaluation of binding competition and group epitopes of acetylcholinesterase inhibitors by STD NMR, Tr-NOESY, DOSY and molecular docking: an old approach but new findings

Back to tab navigation

Supplementary files

Publication details

The article was received on 31 May 2015, accepted on 01 Sep 2015 and first published on 03 Sep 2015


Article type: Concise Article
DOI: 10.1039/C5MD00231A
Citation: Med. Chem. Commun., 2015,6, 1882-1890

  •   Request permissions

    Evaluation of binding competition and group epitopes of acetylcholinesterase inhibitors by STD NMR, Tr-NOESY, DOSY and molecular docking: an old approach but new findings

    N. U. Tanoli, S. A. K. Tanoli, A. G. Ferreira, S. Gul and Z. Ul-Haq, Med. Chem. Commun., 2015, 6, 1882
    DOI: 10.1039/C5MD00231A

Search articles by author

Spotlight

Advertisements